Schrodinger Inc’s stock reached a new 52-week low, dipping to $16.60, reflecting a challenging year for the company. According to InvestingPro data, the stock is trading just 1.02% above its 52-week ...

A downtrend has been apparent in Schrodinger, Inc. (SDGR) lately. While the stock has lost 15.5% over the past week, it could witness a trend reversal as a hammer chart pattern was formed in its last ...

Total Revenue: $54.3 million, a 54% increase from Q3 2024. Software Revenue: $40.9 million, a 28% increase year-over-year. Drug Discovery Revenue: $13.5 million, up from $3.4 million in Q3 2024.

The delegation of the Party Central Committee led by Politburo member, Secretary of the Party Central Committee and President of the Vietnam Fatherland Front Central Committee Do Van Chien; the ...

Dr. Nguyen Hien Phuong appointed as CEO of Vietnamobile. Before her appointment, Dr. Nguyen Hien Phuong had been closely associated with the Hanoi Telecom ecosystem for many years, holding senior ...

The Observatory for the Protection of Human Rights Defenders, a partnership of the International Federation for Human Rights (FIDH) and the World Organisation Against Torture (OMCT), has received new ...

Update: On September 27, 2025, a court in Da Nang convicted and sentenced Trinh Ba Phuong, already serving a 10-year sentence, to an additional 11 years for criticizing the Communist Party of Vietnam.

Robert Abel, chief scientific officer at Schrödinger, says advanced computational tools are changing the pace and accuracy of drug discovery. In a recent episode of The Top Line podcast, Abel outlined ...

Citi downgraded Schrodinger (NASDAQ:SDGR) to Neutral from Buy after the AI-focused biotech announced its decision to discontinue a clinical program for a leukemia candidate following the emergence of ...

Publisher Shueisha Games and developer Acrobatic Chirimenjako have released the second trailer for spirit adventure game Schrodinger’s Call. The game will also be playable at BitSummit the 13th, which ...

Schrodinger has won U.S. Food and Drug Administration fast-track designation for its SGR-1505 drug candidate in a rare type of non-Hodgkin's lymphoma. Schrodinger on Friday said the designation covers ...